Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial (Q28252396)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial	scientific article

Statements

instance of

scholarly article

0 references

title

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial (English)

0 references

main subject

thalidomide

0 references

randomized experiment

1 reference

based on heuristic

inferred from title

stem cell transplantation

1 reference

based on heuristic

inferred from title

multiple myeloma

1 reference

based on heuristic

inferred from title

author

Cyrille Hulin

series ordinal

3

object named as

Cyrille Hulin

0 references

Hervé Avet-Loiseau

series ordinal

27

object named as

Hervé Avet-Loiseau

0 references

Brigitte Pegourie

series ordinal

6

object named as

Brigitte Pegourie

0 references

Carine Chaleteix

series ordinal

10

object named as

Carine Chaleteix

0 references

Ibrahim Yakoub-Agha

object named as

Ibrahim Yakoub-Agha

series ordinal

25

0 references

Thierry Facon

series ordinal

1

object named as

Thierry Facon

0 references

author name string

Jean Yves Mary

series ordinal

2

0 references

Lotfi Benboubker

series ordinal

4

0 references

Michel Attal

series ordinal

5

0 references

Marc Renaud

series ordinal

7

0 references

Jean Luc Harousseau

series ordinal

8

0 references

Gaëlle Guillerm

series ordinal

9

0 references

Mamoun Dib

series ordinal

11

0 references

Laurent Voillat

series ordinal

12

0 references

Hervé Maisonneuve

series ordinal

13

0 references

Jacques Troncy

series ordinal

14

0 references

Véronique Dorvaux

series ordinal

15

0 references

Mathieu Monconduit

series ordinal

16

0 references

Claude Martin

series ordinal

17

0 references

Philippe Casassus

series ordinal

18

0 references

Jérôme Jaubert

series ordinal

19

0 references

Henry Jardel

series ordinal

20

0 references

Chantal Doyen

series ordinal

21

0 references

Brigitte Kolb

series ordinal

22

0 references

Bruno Anglaret

series ordinal

23

0 references

Bernard Grosbois

series ordinal

24

0 references

Claire Mathiot

series ordinal

26

0 references

language of work or name

English

0 references

publication date

6 October 2007

0 references

published in

The Lancet

0 references

volume

370

0 references

issue

9594

0 references

page(s)

1209-18

0 references

uses

randomized experiment

0 references

cites work

Multiple myeloma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor activity of thalidomide in refractory multiple myeloma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Thalidomide and hematopoietic-cell transplantation for multiple myeloma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Single versus double autologous stem-cell transplantation for multiple myeloma.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance therapy with thalidomide improves survival in patients with multiple myeloma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

International staging system for multiple myeloma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0140-6736(07)61537-2

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1886780

OpenCitations bibliographic resource ID

1886780

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1886780

PubMed publication ID

17920916

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1886780

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28252396&oldid=1620760231"